Our Pricing

Is Wegovy Semaglutide? Get Your Online Prescription in 3 Minutes

Published on: June 03, 2026

Wondering is Wegovy semaglutide online prescription UK available quickly and affordably? The short answer is yes—Wegovy is the brand name for semaglutide 2.4mg, the once-weekly injection licensed by the MHRA for weight management. At Cured Pharmacy, you can complete a free online consultation with a UK prescriber in under 3 minutes and access genuine Wegovy from £79.00, with transparent pricing shown upfront before you start.

Is Wegovy Semaglutide? Understanding the Medication

Wegovy is semaglutide—specifically, it's the brand name for semaglutide 2.4mg formulated for chronic weight management in adults with a BMI of 30 or above, or 27 or above with weight-related health conditions [1]. Semaglutide is a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1, which regulates appetite and food intake by acting on areas of the brain involved in hunger control.

The same active ingredient, semaglutide, is also marketed under the brand name Ozempic for type 2 diabetes management, but at lower doses (0.5mg and 1mg). Wegovy's higher 2.4mg dose is specifically licensed for weight loss, following extensive clinical trials demonstrating its efficacy in this indication [1][2]. When patients ask whether Wegovy and semaglutide are different, the answer is straightforward: Wegovy is semaglutide, just as paracetamol is the active ingredient in branded products like Calpol.

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) and the UK-registered clinical team ensure that every patient receives the correct formulation based on their individual health assessment. All Wegovy prescriptions require a clinical consultation with a UK prescriber to confirm suitability, medical history, and current medications.

How Semaglutide (Wegovy) Works for Weight Loss

Semaglutide works by activating GLP-1 receptors in the brain, pancreas, and gastrointestinal tract. This multi-system action reduces appetite, slows gastric emptying (making you feel fuller for longer), and improves blood sugar regulation [2]. In the landmark STEP 1 trial, participants using semaglutide 2.4mg alongside lifestyle interventions achieved an average weight reduction of 14.9% over 68 weeks, compared to 2.4% in the placebo group [2].

The once-weekly injection format improves adherence compared to daily medications. Patients typically start on a low dose (0.25mg) and gradually escalate over 16-20 weeks to the maintenance dose of 2.4mg, minimising gastrointestinal side effects during the titration phase [3]. This dose-escalation schedule is carefully designed based on clinical trial data and is a key part of safe prescribing practice in the UK.

It's important to note that semaglutide is not a quick fix—clinical trials required participants to combine the medication with reduced-calorie diets and increased physical activity [2]. Your UK prescriber will discuss realistic expectations, lifestyle modifications, and monitoring requirements during your consultation.

Expected Results and Timeline

Most patients begin noticing reduced appetite within the first 1-2 weeks of starting semaglutide, though measurable weight loss typically becomes evident after 4-8 weeks [2]. The STEP trials demonstrated that the majority of weight loss occurred within the first 60 weeks of treatment, with weight stabilisation thereafter when combined with ongoing lifestyle changes [2][3]. Individual results vary based on starting weight, adherence to the prescribed regimen, diet quality, and activity levels.

Getting Your Wegovy Prescription Online in the UK

At Cured Pharmacy, the online prescription process for Wegovy takes under 3 minutes to complete. You'll answer a series of clinical questions covering your weight history, current medications, cardiovascular health, and any history of thyroid conditions or pancreatitis. A UK-registered prescriber reviews your assessment—typically within hours—and issues a prescription if clinically appropriate.

All Wegovy supplied by Cured Pharmacy is UK-licensed and sourced through regulated pharmaceutical wholesalers. We never supply unlicensed imports or compounded versions. Pricing is transparent: Wegovy starts from £79.00, with the exact cost determined by your prescribed dose and treatment duration. Unlike some providers, we show prices before you complete the consultation, so there are no surprises at checkout.

Once your prescription is approved, your medication is dispensed by our GPhC-registered pharmacy (registration number 9012511) and dispatched in 100% discreet packaging via next-day or nominated-day delivery. You'll receive clear instructions on injection technique, storage (Wegovy must be refrigerated until first use), and what to do if you miss a dose.

Who Can Be Prescribed Wegovy?

NICE and MHRA guidance specify that semaglutide 2.4mg is suitable for adults with a BMI of 30kg/m² or above, or 27kg/m² or above if you have at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [4]. Wegovy is not licensed for individuals under 18, pregnant or breastfeeding women, or those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1][4]. Your prescriber will assess these criteria during your consultation.

Wegovy vs Other Semaglutide Products: What's the Difference?

Patients often ask about the difference between Wegovy, Ozempic, and Rybelsus—all of which contain semaglutide but are licensed for different indications and available in different formulations. Ozempic is licensed for type 2 diabetes and comes in 0.5mg and 1mg doses, while Rybelsus is an oral tablet form of semaglutide also used for diabetes management. Wegovy is the only semaglutide product licensed specifically for chronic weight management at the 2.4mg dose [1].

Using Ozempic off-label for weight loss has become common due to supply shortages of Wegovy, but this practice is not recommended by UK regulatory bodies. Off-label use means the medication is prescribed outside its licensed indication, which can affect insurance coverage, safety monitoring, and patient support. At Cured Pharmacy, we only prescribe medications within their licensed indications to ensure you receive the appropriate dose, monitoring, and clinical oversight.

Some patients also enquire about compounded semaglutide products available online. These are not licensed by the MHRA and do not undergo the same rigorous quality, safety, and efficacy testing as branded Wegovy. Our clinical team only dispenses MHRA-licensed medicines to guarantee product integrity and patient safety.

Common Side Effects and How to Manage Them

The most frequently reported side effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and abdominal discomfort [3]. In the STEP trials, these effects were generally mild to moderate and decreased over time as patients adjusted to the medication [2][3]. Starting at a low dose and escalating gradually significantly reduces the risk and severity of these symptoms.

To minimise nausea, patients are advised to eat smaller, more frequent meals, avoid high-fat or spicy foods, and stay well-hydrated. If nausea persists beyond the first few weeks or becomes severe, contact your prescriber—they may recommend slowing the dose escalation or prescribing an anti-emetic. Constipation can usually be managed with increased fibre intake, adequate hydration, and gentle physical activity.

Serious but rare side effects include pancreatitis (inflammation of the pancreas), gallbladder problems, and hypoglycaemia if used alongside other glucose-lowering medications [4]. Patients should seek urgent medical attention if they experience severe, persistent abdominal pain, especially if it radiates to the back. Your prescriber will review your full medication list during consultation to identify any potential interactions or contraindications.

When to Contact Your Prescriber

You should contact your UK prescriber if you experience severe or persistent side effects, signs of an allergic reaction (rash, swelling, difficulty breathing), or if you're not tolerating the dose escalation schedule. Regular follow-up is recommended every 3-6 months to monitor weight loss progress, adjust doses if needed, and assess whether continued treatment remains clinically appropriate [4].

Pricing, Delivery, and Ongoing Support at Cured Pharmacy

Wegovy pricing at Cured Pharmacy starts from £79.00, with transparent costs displayed before you begin your consultation. We guarantee the lowest prices in the UK for genuine, MHRA-licensed weight loss treatments. There are no hidden fees—the price you see includes the medication, clinical consultation, prescription, and delivery.

All orders are dispatched in 100% discreet packaging with no external branding or indication of contents. You can choose next-day delivery or nominate a specific delivery date to suit your schedule. Once your first prescription is issued, you'll have access to ongoing clinical support via our patient portal, where you can request repeat prescriptions, report side effects, or ask questions to our UK-registered pharmacists.

We also provide comprehensive patient information leaflets, injection technique videos, and guidance on safe disposal of used needles. Our superintendent pharmacist Tarun Kumar and the clinical team are available by phone ((+44) 116 4646009) during business hours if you need personalised advice or have concerns about your treatment. At Cured Pharmacy, we're committed to supporting your weight loss journey with expert clinical care, not just dispensing medication.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy (semaglutide) is a prescription-only medicine and may not be suitable for everyone. Individual results may vary and are not guaranteed.